维普中文期刊产品整合服务
211篇 您的检索式:作者名="HARUTA Y"
    题名 作者 年代 出处 被引量
1Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin显示文摘Takahashi N Kawanishi Tabata R Haba A Tabata M Haruta Y Tsai H 2001Clin Cancer Res2001,7,:1
2Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies 显示文摘Matsuno F Haruta Y Kondo M 1999Clin Cancer Res1999,5,2:1
3Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies显示文摘Matsuno F Haruta Y Kondo M 1999Clin Cancer Res1999,5,:1
4Keten silyl acetal chemistry; simple synthesis of methyl jasmonate and related compounds by utilising keten methyl dimethyl-t-butylsilyl acetal显示文摘Kita Y Segawa J Haruta J 1982Journal of the Chemical Society Perkin Transactions 11982,,4:1
5Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin 显示文摘Seon BK Matsuno F Haruta Y 1997Clin Cancer Res1997,3,7:1
6Long-lasting complete inhibition of human solid tumors in SCID mile by targeting endothelial cells of tumor Vascutature with antihuman endoglin immunotoxin显示文摘Seno BK Matsuno F Haruta Y 1997Chin Cancer Res1997,3,6:1
7Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using 125I-labeled anti-endoglin monoclonal antibodies 显示文摘Tabata M Kondo M Haruta Y 1999Int J Cancer1999,82,5:1
8Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies 显示文摘Matsuno F Haruta Y Kondo M 1999Clin Cancer Res1999,5,2:1
9Induction of last- ing complete regression of preformed distinct solid tumors by targe- ting the tumor vasculature using two new anti - endoglin mono- clonal antibodies显示文摘MATSUNO F HARUTA Y KONDO M 1999Clin Cancer Res1999,5,2:1
10Effects of the addition of beta 2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma显示文摘Hozawa S Haruta Y Terada M 2009Allergol Int2009,58,:1
11Circulating natural killer T cells in patients with asthma 显示文摘Ikegami Y Yokoyama A Haruta Y 2004J Asthma2004,41,8:1
12Circulating natural killer T cells in patients with asthma显示文摘Ikegami Y Yokoyama A Haruta Y 2004J Asthma2004,41,:1
13Molecular geneticsand epidemiology of epithelial ovarian cancer(Review)显示文摘Haruta S Furukawa N Yoshizawa Y 2011Oncol Rep2011,26,6:1
14Effect of addition of beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma显示文摘Hozawa S Haruta Y Terada M 2009Allergol Int2009,58,4:1
15Activation of mammalian target ofrapamycin in postmenopausal ovarian endometriosis 显示文摘Yagyu T Tsuji Y Haruta S 2006Int J Gyne-col Cancer2006,16,4:1
16Video : laparoscopy dis- tinctive technique for suprapancreatic lymphnode dissection : medi- al approach for laparoscopic gastric cancer surgery 显示文摘Kanaya S Haruta S Kawamura Y 2011Surg Endosc2011,25,12:1
17Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor varsculature with antihu man CD34 immunotoxin显示文摘Seon BK Matsuno F Haruta Y 1997Clin Cancer Res1997,3,3:1
18Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin显示文摘 Matsuno F Haruta Y 1997Clin Cancer Res1997,3,:1
19Microbial community in anaerobic hydrogen producing micro? ora enriched from sludge compost 显示文摘Ueno Y Haruta S Igarashi Y 2001Applied Microbiology and Biotechnology2001,57,4:1
20Multiple logistic re-gression analysis of risk factors for the development of steroid-de-pendent asthma in the elderly:a comparison with younger asthmat-ics显示文摘Ishioka S Terada M Haruta Y 2001Respiration2001,68,1:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费